↓ Skip to main content

IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis

Overview of attention for article published in Frontiers in Pharmacology, March 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
Published in
Frontiers in Pharmacology, March 2023
DOI 10.3389/fphar.2023.1124628
Pubmed ID
Authors

Zhenzhen Deng, Shengfeng Wang, Cuifang Wu, Chunjiang Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 17%
Student > Bachelor 2 8%
Student > Master 2 8%
Other 1 4%
Researcher 1 4%
Other 0 0%
Unknown 14 58%
Readers by discipline Count As %
Medicine and Dentistry 4 17%
Agricultural and Biological Sciences 2 8%
Immunology and Microbiology 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 15 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2024.
All research outputs
#3,624,127
of 25,385,509 outputs
Outputs from Frontiers in Pharmacology
#1,756
of 19,728 outputs
Outputs of similar age
#69,280
of 421,785 outputs
Outputs of similar age from Frontiers in Pharmacology
#44
of 940 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,728 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 940 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.